Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis

American Journal of Gastroenterology

Volumn 99, Issue 5, 2004, Pages 777-785

  Williams, R B H ^b   Szczesniak, M M ^b   Maclean, J C ^b   Brake, H M ^b   Cole, I E ^b   Cook, Ian J ^a  

^a ST GEORGE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; ESOPHAGUS MANOMETRY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGITIS; LARYNGOSCOPY; MALE; OPEN STUDY; PRIORITY JOURNAL; VOICE; ANALYSIS OF VARIANCE; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; ORAL DRUG ADMINISTRATION; PH; PREDICTION AND FORECASTING; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANALYSIS OF VARIANCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; LARYNGITIS; LARYNGOSCOPY; MALE; MIDDLE AGED; OBSERVER VARIATION; OMEPRAZOLE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 2942642649     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.04151.x     Document Type: Article

References (34)

1. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(Suppl 53):1-78.
2. Shaker R, Milbrath M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 1995;109:1575-82.
3. Richter JE. Gastroesophageal reflux disease and asthma: The two are directly related. Am J Med 2000;108(Suppl 4a):153S-158S.
4. Katz PO. Ambulatory esophageal and hypopharyngeal pH monitoring in patients with hoarseness. Am J Gastroenterol 1990;85(1):38-40.
5. Kambic V, Radsel Z. Acid posterior laryngitis. Aetiology, histology, diagnosis and treatment. J Laryngol Otol 1984;98(12):1237-40.
6. Ylitalo R, Ramel S. Gastroesophagopharyngeal reflux in patients with contact granuloma: A prospective controlled study. Ann Otol Rhinol Laryngol 2002;111(2):178-83.
7. Jacob P, Kahrilas PJ, Herzon G. Proximal esophageal pH-metry in patients with "reflux laryngitis." Gastroenterology 1991;100(2):305-10.
8. Wilson JA, White A, von Haacke NP, et al. Gastroesophageal reflux and posterior laryngitis. Ann Otol Rhinol Laryngol 1989;98(6):405-10.
9. Sackett D, Haynes R, Tugwell P. Clinical epidemiology. In: A basic science for clinical medicine. Toronto: Little Brown and Company, 1985.
10. Nostrant TT. Gastroesophageal reflux and laryngitis: A skeptic's view. Am J Med 2000;108(Suppl 4a):149S-152S.
11. Kamel PL, Hanson D, Kahrilas PJ. Omeprazole for the treatment of posterior laryngitis. Am J Med 1994;96:321-6.
12. Hanson DG, Kamel PL, Kahrilas PJ. Outcomes of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995;104:550-5.
13. Jaspersen D, Weber R, Hammar CH, et al. Effect of omeprazole on the course of associated esophagitis and laryngitis. J Gastroenterol 1996;31(6):765-7.
14. Shaw GY, Searl JP. Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeparazole. South Med J 1997;90(11):1115-22.
15. Wo JM, Grist WJ, Gussack G, et al. Empiric trial of high dose omeprazole in patients with posterior laryngitis. Am J Gastroenterol 1997;92(12):2160-5.
16. Habermann W, Eherer A, Lindbichler F, et al. Ex juvantibus approach for chronic posterior laryngitis: Results of short-term pantoprazole therapy. J Laryngol Otol 1999;113(8):734-9.
17. Ulualp SO, Toohill RJ, Shaker R. Outcomes of acid suppressive therapy in patients with posterior laryngitis. Otolaryngol Head Neck Surg 2001;124(1):16-22.
18. Havas T, Huang S, Levy M, et al. Posterior pharyngolaryngitis. Double blind randomised controlled trial of proton pump inhibitor therapy. Aust J Otolaryng 1999;3(3): 243-6.
19. El-Serag HB, Lee P, Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: A placebo controlled trial. Am J Gastroenterol 2001;96(4): 979-83.
20. Anonymous. Workshop consensus reports from the first multidisciplinary international symposium on supraesopahgeal complications of gastroesophageal reflux disease. Am J Med 1997;103(5A (Suppl):149S-150S.
21. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33(2):363-74.
22. Fairbank G. Voice and articulation drillbook. 2nd ed. New York: Harper and Row, 1960.
23. Troughear RH, Davis PJ. Real-time, micro-processor based feature extraction in a speech pathology clinic. Austr J Commun Disorders 1979;7:4-21.
24. Davis PJ, Boone DR, Carroll RL, et al. Adductor spastic dysphonia: heterogeneity of physiologic and phonatory characteristics. Ann Otol Rhinol Laryngol 1988;97:179-85.
25. Emde C, Garner A, Blum AL. Technical aspects of intraluminal pH-metry in man: Current status and recommendations. Gut 1987;88:1177-88.
26. Williams RB, Ali GN, Wallace KL, et al. Esophagopharyngeal acid regurgitation: Dual pH monitoring criteria for its detection and insights into mechanisms. Gastroenterology 1999;117:1051-61.
27. Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull 1971;76:378-82.
28. Siegel S, Castellan NJJ. Nonparametric statistic for the behavioral sciences. New York: McGraw-Hill Book Company, 1988.
29. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111(8):1313-17.
30. Belafsky PC, Postma GN, Koufman JA. Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 2001;111(6):979-81.
31. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management. The Genval workshop report. Gut 1999;44(Suppl 2):S1-S6.
32. Reulbach TR, Belafsky PC, Blalock PD, et al. Occult laryngeal pathology in a community-based cohort. Otol Head Neck Surg 2001;124(4):448-50.
33. Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002;16:564-79.
34. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology 1996;111(1):85-92.